| 摘要 |
The present invention relates to treatment and/or prevention of one or more metabolic disorders utilizing fatostatin A and/or a derivative and/or analog thereof. In other aspects, the compound for treatment and/or prevention of one or more metabolic disorders utilizes an A-B-C tripartite structure, wherein A, B, and C are identical or non-identical structures and are described in detail herein. In specific aspects, the metabolic disorder includes obesity or diabetes, for example. |
| 申请人 |
BAYLOR COLLEGE OF MEDICINE;UESUGI, MOTONARI;WAKIL, SALIH, J.;ABU-ELHEIGA, LUTFI;MAO, QIAN;KAMISUKI, SHINJI;KUGIMIYA, AKIRA |
发明人 |
UESUGI, MOTONARI;WAKIL, SALIH, J.;ABU-ELHEIGA, LUTFI;MAO, QIAN;KAMISUKI, SHINJI;KUGIMIYA, AKIRA |
